Lawrence Waldman - 11 Jul 2022 Form 4 Insider Report for Apyx Medical Corp (APYX)

Role
Director
Signature
/s/ Lawrence Waldman
Issuer symbol
APYX
Transactions as of
11 Jul 2022
Net transactions value
+$60,960
Form type
4
Filing time
11 Jul 2022, 16:54:48 UTC
Previous filing
23 May 2022
Next filing
17 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APYX Common Stock Options Exercise $60,960 +24,000 +177% $2.54 37,563 11 Jul 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APYX Stock Option (Option to Buy) Options Exercise $0 -24,000 -100% $0.000000* 0 11 Jul 2022 Common Stock 24,000 $2.54 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting Person was granted a stock option that vested and became exercisable over 3 years at a rate of 33.33% of the option on the anniversary date of each succeeding year.